Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Parity Group Plc LSE:PTY London Ordinary Share GB00B1235860 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 2.86% 9.00 8.50 9.50 9.00 8.75 8.75 194,099 08:36:36
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 80.4 -1.1 -1.1 - 9

Parity Share Discussion Threads

Showing 7601 to 7624 of 7725 messages
Chat Pages: 309  308  307  306  305  304  303  302  301  300  299  298  Older
DateSubjectAuthorDiscuss
09/12/2019
08:57
Nicely up this morning. Lowest ask on show is up at the 10.50p and on a vg vol. PTY being well wanted, these days. f
fillipe
08/12/2019
19:05
https://www.youtube.com/watch?v=2w3oZEfmbk0
onjohn
08/12/2019
18:59
https://www.youtube.com/watch?v=WtjYIzSTcks
napoleon 14th
06/12/2019
15:53
ONJohn, on the 19th of November 2 directors bought shares. Now is it likely they would buy with a profit warning coming? Of course not. Now don’t post just to scare newbies.
rafboy
06/12/2019
15:49
Two can play at that game and both posts are worthless!
rafboy
06/12/2019
15:49
NO PROFIT WARNING COMING IMHO
rafboy
05/12/2019
15:08
PROFIT WARNING COMING IMHO
onjohn
05/12/2019
14:05
Apologies Parity holders as my post probably more at home on the Integumen board.
flashheart
05/12/2019
14:04
I've already been contemplating that Katsy as well. Not beyond the realms of possibility although a major transaction. Imagine the company in the making in the result though eh......mind boggling. Whatever the result and the reason behind the recent share price weakness (for no apparent reason as yet) I'm confident GB has all avenues covered and is building a beast to be reckoned with.
flashheart
05/12/2019
13:56
Could this be a target for Integumen if indeed they are raising funds for an acquisition? c£10m Mcap with multople of that in revenue. If GB could cut cost and streamline the business like he's done for Integumen it could be a very profitable business. It would mean a massive dilution for SKIN shareholders though.
katsy
04/12/2019
06:46
Well a few token shares purchased by director and its market cap went up bu a third. Really. REALLY !!!
my retirement fund
19/11/2019
09:54
Agree. It's looking cheap with huge potential.
insideryou
19/11/2019
08:10
Great if it would do the same rerating that SKIN had with data and be a multibagger
mulligut
19/11/2019
07:31
I am an investor in SKIN but am watching here with interest. Low market cap, high turnover and a new management team all point to a possible multi-bagger even after a 50% rise.
parsons4
15/11/2019
16:10
ONJohnIs it not about time that you kept it shut?
thorne3
15/11/2019
13:24
Asking 9.5p now an that almost being paid. f
fillipe
15/11/2019
10:59
Indeed, that deal could well prove very good for both companies.
rafboy
15/11/2019
10:39
Yes and the price is moving up with the recent deal announcement of Integumen too
mulligut
15/11/2019
10:38
Nice to see interest growing here with a few buys this morning.
rafboy
13/11/2019
10:10
Todays news One sad sack doing a deal with an equally sad sack
onjohn
13/11/2019
09:29
I bought shares here off the back of the SKIN partnership. I expect both companies to do well out of this deal.
soultrading
13/11/2019
07:58
Parity Group PLC HoT regarding revenue share on AI data platformSource: UK Regulatory (RNS & others)TIDMPTYRNS Number : 1793TParity Group PLC13 November 201913 November 2019AIM: PTYParity Group PLC("Parity" or "Company")Parity shares revenue with Integumen plc to deliver AI data platform solutions to clientsParity announces that it has signed Heads of Terms with Integumen plc to enter a multi-year Framework Agreement ("Agreement") to be completed on or before the 18th of December 2019. It is envisaged that the Agreement will give Parity access to Integumen's Artificial Intelligent ("AI") software which it can supply across its client base which includes the National Health Service ("NHS"), Central Government and Private Institutional clients.This Agreement accelerates Parity's transformation from a predominately commoditised recruitment business to a data consultancy service provider of intelligent data management systems, extracting value using analytics, with a focus on return on investment for our Company's 100+ institutional clients. The software includes full GDPR compliance with secure cloud data migration from existing legacy systems to a digital workplace through the military grade encryption "Drive4Growth" AI platform powered by Integumen's Rinodrive.Combined benefits:-- Recurring shared revenue streams for both Parity and Integumen in 2020 -- Value-added proposition in demand from Parity clients with c. 3 to 5-year annual contracts -- Immediate access to 100+ public and private institutional clients -- Trusted approved vendor for Government and private sectors for over 45 years -- 700+ data experts and 50+ enterprise sales and office professionals -- Existing cross-over access to educational institutional research facilities -- Access to multiple industry, public and private sector distribution routes to market -- Well defined roadmap to next level business growth for both Parity and Integumen Since the appointment of the new CEO, in February 2019, there has been structural changes to the business. Client management focus is on increasing profitability. New senior management has reduced high-volume low-margin business to low-volume high-margin multi-line business development. This includes new, higher value data expert professional service offerings. Reduction in headcount of 35% has resulted in a rolling 12-month gross cost saving of GBP2m. Heading into 2020 with these changes and with today's agreement, the board expect the Company will deliver a right-sized company with higher margins, increased profitability leading to improved shareholder value.Matthew Bayfield, CEO of Parity Group plc, comments:"Parity is pleased to be partnering with Integumen and rolling out the Drive4Growth AI platform to our client base. We have been working with many of the same clients for 45 years, so we understand their needs. With healthcare sector data in 2020 expected to double every 73 days, our clients need to securely manage and extract greater value using analytics and AI in order to make important decisions. The Drive4Growth AI platform delivers on those requirements, increases revenue per client, increases client contract term and generates a higher margin, leading to greater profitability."Gerard Brandon, CEO of Integumen plc, comments:"We are delighted to be able to roll-out the Drive4Growth AI platform in partnership with the credibility and reputation that Parity data experts hold with an extensive list of public and private institutions. We look forward to working alongside Parity to extract greater value for their clients and contribute to the transformation of the UK's National Health Service, public and private institution data over the next few years."Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.ContactsMatthew Bayfield, CEO +44 (0) 208 543 Parity Group plc Roger Antony, GFD 5353 WH Ireland Limited Mike Coe +44 (0) 117 945 (Nominated Adviser & Broker) Chris Savidge 3470 -------------------- ----------------- +44 (0) 7836 293 Donhead Consultants (Broker) David Beck 383 -------------------- ----------------- About Parity Group: www.parity.netParity helps organisations find the right people, skills and data to support data-led business decisions. Providing advice on data and with access to qualified personnel with skills offered, either as a managed service, through resourcing in the contract or permanent market or as part of a learning and development programme.Income derives from a mix of long-term contracts with public and private sector organisations as well as expanded projects with existing clients as a result of strong relationships and a track record of high client satisfaction. Key highlights comprising of:-- Over 45 years of expertise in public and private recruitment and service contract sector -- More than 50 employees across the UK -- Client numbers exceed 100 in both UK and Ireland -- Associate numbers supporting client services exceeds 700 About Integumen: www.integumen.comIntegumen is a vertically integrated product and services company for skin related diseases, treatments and therapies with four business units:-- Labskin AI's technology platform incorporates artificial intelligence within clinical research for medical device, pharmaceuticals, cosmeceuticals and related life science test services. Labskin allows skincare, healthcare, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.-- Rinodrive is a data aggregation, refining and AI analysis open-source eco-system designed to provide third-party service providers the ability to offer their clients valuable insights that support clinical, operational and financial decisions in healthcare services, third-level education, government departments and the financial sector.-- Wound pHase is developing skin and wound care products using its proprietary wound dressing technology. Working in collaboration with CBD providers creating a CBD infused diabetic wound care product range.-- Stoer-for-men skin products e-commerce division offers a range of skincare products derived from 5 natural super-ingredient plant extracts specifically for men to reduce the signs of ageing and is also used as a control for client testing within Labskin laboratories.RinoDrive "Drive4Growth": www.rinodrive.comA fully integrated set of software tools that can ingest data, in any volume, from any source in any format, interact with it, learn from it and enrich it to unlock insights and discoveries.This data management solution was developed by scientists and engineers with experience in software, sensors, AI, optofluidic research, fintech, green-tech, travel and healthcare.It was designed to allow interaction, in a cyber-secure environment, with commercially sensitive data, and to share insights across multi-disciplinary teams, generating different data formats, from multiple sources, located in different countries.RinoDrive delivers big data, AI functionality and world class infrastructure to large companies with big data problems. These include financial services, education and life science companies. Most recently completing the automation of laboratories and application of AI to unearth more knowledge about the skin microbiome. This led to the acquisition in May 2019 by Integumen PLC, to secure access to, and the exploitation of data from some of the largest cosmetic, pharmaceutical and medical companies in the world.This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDAGRFFIFWEFUSEFF(END) Dow Jones NewswiresNovember 13, 2019 02:00 ET (07:00 GMT)
insideryou
20/9/2019
11:50
Interesting first post cricket!
tiswas
20/9/2019
11:28
This is an amazing achievement from a new CEO who in just 4 months has taken out over £1m of net costs, reorganised and refocused the business and made key new hires. With existing retained revenues of circa £44.5m, even if full year revenue allowing for the loss of the Scottish contract already announced,was only £70m the potential profits on margin improvement to just 5% would make the present market cap of the company look ridiculous. An exciting turnaround with big upside potential.
cricketcrazy
Chat Pages: 309  308  307  306  305  304  303  302  301  300  299  298  Older
ADVFN Advertorial
Your Recent History
LSE
PTY
Parity
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201203 02:00:13